Molina Healthcare (NYSE:MOH) Price Target Cut to $331.00

Molina Healthcare (NYSE:MOH) had its price target dropped by analysts at Robert W. Baird from $405.00 to $331.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Robert W. Baird’s price objective suggests a potential upside of 20.48% from the company’s previous close.

Several other equities analysts have also issued reports on the company. Cantor Fitzgerald reiterated an “overweight” rating and issued a $406.00 price objective on shares of Molina Healthcare in a research report on Tuesday, October 1st. Stephens reiterated an “equal weight” rating and issued a $320.00 price objective on shares of Molina Healthcare in a research report on Thursday, July 25th. Jefferies Financial Group decreased their price objective on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research report on Wednesday, July 24th. TD Cowen reduced their price target on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a research report on Wednesday, July 24th. Finally, StockNews.com raised Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. One analyst has rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $371.83.

Molina Healthcare Stock Performance

Shares of MOH stock opened at $274.73 on Thursday. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.57 and a quick ratio of 1.57. The stock has a market cap of $16.10 billion, a PE ratio of 14.91, a price-to-earnings-growth ratio of 1.15 and a beta of 0.58. The stock has a 50-day moving average of $336.17 and a 200-day moving average of $330.51. Molina Healthcare has a one year low of $272.69 and a one year high of $423.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.73 by $0.13. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. The business had revenue of $9.88 billion during the quarter, compared to analyst estimates of $9.75 billion. During the same period in the previous year, the firm earned $5.65 EPS. Molina Healthcare’s quarterly revenue was up 18.7% compared to the same quarter last year. As a group, sell-side analysts expect that Molina Healthcare will post 23.5 earnings per share for the current year.

Insider Activity at Molina Healthcare

In related news, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the sale, the director now owns 18,025 shares in the company, valued at approximately $6,114,260.25. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Molina Healthcare news, CAO Maurice Hebert sold 393 shares of the stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the transaction, the chief accounting officer now owns 9,473 shares in the company, valued at $3,282,583.96. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Steven J. Orlando sold 1,000 shares of the stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the transaction, the director now owns 18,025 shares in the company, valued at $6,114,260.25. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 1.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the company. Innealta Capital LLC bought a new position in Molina Healthcare during the 2nd quarter worth $36,000. Ashton Thomas Private Wealth LLC bought a new position in Molina Healthcare during the 2nd quarter worth $40,000. AM Squared Ltd bought a new position in Molina Healthcare during the 2nd quarter worth $59,000. UMB Bank n.a. increased its position in shares of Molina Healthcare by 96.2% in the third quarter. UMB Bank n.a. now owns 206 shares of the company’s stock worth $71,000 after purchasing an additional 101 shares during the period. Finally, Fidelis Capital Partners LLC bought a new position in shares of Molina Healthcare in the first quarter worth $151,000. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.